Submission Details
| 510(k) Number | K200574 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 05, 2020 |
| Decision Date | June 19, 2020 |
| Days to Decision | 106 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
K200574 is an FDA 510(k) clearance for the EksoNR, a Powered Exoskeleton (Class II — Special Controls, product code PHL), submitted by Ekso Bionics, Inc. (Richmond, US). The FDA issued a Cleared decision on June 19, 2020, 106 days after receiving the submission on March 5, 2020. This device falls under the Neurology review panel. Regulated under 21 CFR 890.3480.
| 510(k) Number | K200574 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 05, 2020 |
| Decision Date | June 19, 2020 |
| Days to Decision | 106 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
| Product Code | PHL — Powered Exoskeleton |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 890.3480 |
| Definition | A Powered Exoskeleton Is A Prescription Device That Is Composed Of An External, Powered, Motorized Orthosis That Is Placed Over A Person's Paralyzed Or Weakened Lower Extremity Limb(s) For Medical Purposes. |